{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:46:53Z","timestamp":1769107613486,"version":"3.49.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0117143","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T13:50:13Z","timestamp":1422453013000},"page":"e0117143","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Dhayana","family":"Dallmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Rajman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Rothenbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2011) Cardiovascular Diseases\u2014Fact Sheet, vol N\u00b0 317."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"VL Roger","year":"2012","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"E Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"JA de Lemos","year":"2001","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)","volume":"52","author":"S Masson","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jacc.2005.06.085","article-title":"Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease","volume":"47","author":"M Richards","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehp420","article-title":"N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population","volume":"31","author":"GC Linssen","year":"2010","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/eurheartj\/ehl448","article-title":"N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population","volume":"28","author":"MH Olsen","year":"2007","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","article-title":"B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies","volume":"120","author":"E Di Angelantonio","year":"2009","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00392-011-0340-1","article-title":"Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?","volume":"100","author":"J Franke","year":"2011","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/cc9398","article-title":"Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure","volume":"15","author":"M Noveanu","year":"2011","journal-title":"Crit Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ahj.2006.08.021","article-title":"Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results","volume":"152","author":"AH Wu","year":"2006","journal-title":"Am Heart J"},{"issue":"16","key":"ref13","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/eurheartj\/ehq509","article-title":"Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care","volume":"33","author":"K Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jacc.2009.07.069","article-title":"Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing","volume":"55","author":"CR deFilippi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amjcard.2007.11.025","article-title":"Amino-terminal pro-B-type natriuretic peptides in stable and unstable ischemic heart disease","volume":"101","author":"T Omland","year":"2008","journal-title":"Am J Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1001\/jama.294.22.2866","article-title":"Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease","volume":"294","author":"DA Morrow","year":"2005","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"M Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"PW Wilson","year":"1998","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"MJ Pencina","year":"2008","journal-title":"Stat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"EW Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1001\/archinte.166.22.2455","article-title":"Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease","volume":"166","author":"D Rothenbacher","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"K Bibbins-Domingo","year":"2007","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"114","author":"S Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jacc.2011.02.041","article-title":"N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease","volume":"58","author":"SG Wannamethee","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa042330","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease","volume":"352","author":"C Kragelund","year":"2005","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/clc.20569","article-title":"N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study","volume":"32","author":"HS Singh","year":"2009","journal-title":"Clin Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults","volume":"293","author":"C Kistorp","year":"2005","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.0000103681.04726.9C","article-title":"B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study","volume":"108","author":"K Bibbins-Domingo","year":"2003","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/clc.20894","article-title":"NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings","volume":"34","author":"S Toggweiler","year":"2011","journal-title":"Clin Cardiol"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Steyerberg EW, Vedder MM, Leening MJ, Postmus D, D\u2019Agostino RB Sr, et al. (2014) Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives. Biom J.","DOI":"10.1002\/bimj.201300260"},{"key":"ref31","unstructured":"ClinicalTrials.gov Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) (CANTOS). pp. NCT01327846."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ahj.2011.07.018","article-title":"Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome","volume":"162","author":"ML O\u2019Donoghue","year":"2011","journal-title":"Am Heart J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0117143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T03:40:12Z","timestamp":1566272412000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0117143"}},"subtitle":[],"editor":[{"given":"Tanja","family":"Zeller","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0117143","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}